• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    South America Piriformis Syndrome Market

    ID: MRFR/HC/55053-HCR
    200 Pages
    Rahul Gotadki
    October 2025

    South America Piriformis Syndrome Market Research Report By Cause (Trauma, Spasms, Others) and By Regional (Brazil, Mexico, Argentina, Rest of South America)- Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    South America Piriformis Syndrome Market Infographic
    Purchase Options

    South America Piriformis Syndrome Market Summary

    The South America Piriformis Syndrome market is projected to grow from 19.5 USD Million in 2024 to 34 USD Million by 2035, indicating a robust growth trajectory.

    Key Market Trends & Highlights

    South America Piriformis Syndrome Key Trends and Highlights

    • The market is expected to achieve a compound annual growth rate (CAGR) of 5.19 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 34 USD Million, reflecting increasing awareness and treatment options.
    • In 2024, the market is valued at 19.5 USD Million, highlighting the current demand for Piriformis Syndrome management solutions.
    • Growing adoption of advanced therapeutic techniques due to rising patient awareness is a major market driver.

    Market Size & Forecast

    2024 Market Size 19.5 (USD Million)
    2035 Market Size 34 (USD Million)
    CAGR (2025-2035) 5.19%

    Major Players

    Zimmer Biomet, Medtronic, DePuy Synthes, Abbott Laboratories, Hologic, Aesculap, Baxter International, Stryker Corporation, ConMed, Thermo Fisher Scientific, Boston Scientific, Invacare Corporation, Smith & Nephew, NuVasive, Johnson & Johnson

    South America Piriformis Syndrome Market Trends

    The South America Piriformis Syndrome Market is witnessing several important trends that shape its growth and development. Increased awareness of musculoskeletal disorders, including piriformis syndrome, is driving more patients to seek treatment options. The rise in obesity rates and sedentary lifestyles within the region contribute to higher incidences of this condition. As healthcare systems in countries like Brazil and Argentina improve, access to physical therapy and alternative treatment methods is expanding, thus empowering patients to pursue effective management strategies. 

    Moreover, the growing trend of utilizing natural remedies and holistic approaches has found a place in the market.There is a growing patient interest in lifestyle-aligned treatment options such as acupuncture, massage therapy, and yoga. At the same time, telehealth services are expanding the ways healthcare practitioners can remotely connect with patients, improving piriformis syndrome management through virtual consultations, which is particularly relevant in South America with its wide geographic dispersal. There's also a shift in the market to create multi-disciplinary treatment regimens that integrate alternative medicine with traditional approaches to holistic medicine to address the condition.

    With local governments pushing initiatives towards better healthcare access and quality, there are substantial opportunities for stakeholders to invest in education and outreach programs that inform the public about piriformis syndrome. This could highlight the importance of early diagnosis and intervention, ultimately enhancing healthcare outcomes across the region.

    Market Segment Insights

    South America Piriformis Syndrome Market Segment Insights

    South America Piriformis Syndrome Market Segment Insights

    Piriformis Syndrome Market Cause Insights

    Piriformis Syndrome Market Cause Insights

    The South America Piriformis Syndrome Market exhibits significant dynamics attributed to the various causes underlying this condition, primarily categorized into Trauma, Spasms, and Others. Trauma is a leading cause, often resulting from physical injuries or repetitive strain, which highlights the increasing relevance of preventative measures and rehabilitation strategies across the region. The prevalence of sports-related injuries within South America, due to the popularity of athletics and recreational sports, contributes to the instances of trauma-induced piriformis syndrome, suggesting a growing need for targeted treatment options and awareness.

    Spasms represent another crucial cause associated with piriformis syndrome, often relating to muscle imbalances or postural issues, which can be exacerbated by lifestyle factors prevalent in urban areas of South America. 

    With an increase in sedentary behavior attributed to urbanization, muscle spasms become more frequent, and thus, the focus on therapeutic interventions and corrective exercise programs gains importance. The market segmentation within the South America Piriformis Syndrome Market not only emphasizes these leading causes but also reveals the necessity for education on posture and ergonomic practices, particularly in work environments that contribute to prolonged sitting.In addition to Trauma and Spasms, the "Others" category encompasses various less common causes, particularly those related to anatomical variation or systemic health conditions.

    This segment brings attention to the diverse etiologies of piriformis syndrome, urging healthcare professionals to adopt a multidisciplinary approach to diagnosis and treatment. 

    Get more detailed insights about South America Piriformis Syndrome Market

    Regional Insights

    The South America Piriformis Syndrome Market demonstrates diverse dynamics across its regional segment, where Brazil, Mexico, Argentina, and the Rest of South America play pivotal roles. Brazil stands out as a significant contributor, owing to its larger population and increasing healthcare investments focusing on musculoskeletal disorders. Meanwhile, Mexico showcases a growing awareness of Piriformis Syndrome, influenced by demographic shifts and a rise in physical activity that can lead to such conditions. 

    Argentina, while smaller in comparison, acknowledges rising incidences of the syndrome, which has propelled healthcare providers to offer targeted therapies.The Rest of South America, comprising various nations, also contributes to market growth through increasing healthcare access and the adoption of innovative treatment options, thereby enhancing patient outcomes. Trends in the South America Piriformis Syndrome Market point toward an expanding focus on rehabilitation, physical therapy, and minimally invasive procedures as viable treatment protocols.

     Challenges such as healthcare accessibility and varying levels of awareness among the population present opportunities for growth and innovation in therapies catering to the syndrome across this region.The overall market momentum is fueled by these regional initiatives, demonstrating a collective response to combatting Piriformis Syndrome within South America.

    South America Piriformis Syndrome Market Region

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Key Players and Competitive Insights

    The South America Piriformis Syndrome Market is emerging as a significant segment within the broader healthcare landscape, particularly due to the increasing prevalence of musculoskeletal disorders in the region. This market is characterized by a competitive environment where various companies strive to offer innovative solutions for managing piriformis syndrome, which often involves a combination of surgical and non-surgical treatments. The competitive insights within this market reveal a dynamic interplay of local and global players focused on advancing medical devices, physical therapies, and surgical interventions aimed at alleviating the symptoms associated with this condition.

    Trends in collaboration, innovation, and patient-centered care are prevalent, with ongoing research and development efforts aimed at enhancing treatment efficacy and patient outcomes in South America.

    Zimmer Biomet holds a strong presence in the South America Piriformis Syndrome Market, underscoring its commitment to providing comprehensive solutions for musculoskeletal challenges. The company is recognized for its innovative orthopedic products and has built a reputation for quality and reliability among healthcare professionals and patients alike. Zimmer Biomet's strength lies in its extensive portfolio of surgical instruments and implants designed specifically for addressing piriformis syndrome, enabling effective interventions and enhancing recovery times.

    Additionally, the company is known for its robust distribution networks and partnerships within South America, ensuring that its products are accessible to healthcare facilities across urban and rural settings. This focused approach allows Zimmer Biomet to effectively contribute to the region's healthcare ecosystem while reinforcing its position in the competitive landscape.

    Medtronic also plays a significant role in the South America Piriformis Syndrome Market, offering a range of medical devices and therapies targeted at pain management and minimally invasive surgical solutions. The company's portfolio includes key products designed for nerve stimulation and targeted drug delivery, catering specifically to patients suffering from conditions like piriformis syndrome. Medtronic's market presence in South America is bolstered by ongoing investments in local manufacturing and distribution, allowing for swift and efficient access to their innovative solutions. With a focus on research and development, Medtronic consistently seeks to enhance its offerings, focusing on patient outcomes and safety.

    The company has also engaged in strategic mergers and acquisitions, which have further expanded its capabilities in pain management and orthopedic solutions, solidifying its competitive advantage in addressing the needs of healthcare providers and patients dealing with piriformis syndrome in the region.

    Key Companies in the South America Piriformis Syndrome Market market include

    Industry Developments

    In South America, recent developments in the Piriformis Syndrome Market have been characterized by an increased focus on orthopedic and pain management solutions, driven by a growing prevalence of musculoskeletal disorders. Companies like Zimmer Biomet and Medtronic are enhancing their product portfolios with advanced surgical instruments and minimally invasive techniques tailored for Piriformis Syndrome treatment. 

    Notably, in June 2023, DePuy Synthes announced an investment in a new facility in Brazil aimed at expanding its capabilities in producing innovative surgical solutions.In terms of market growth, Baxter International has reported a steady increase in the demand for its pain management products, fostering competitive dynamics among key players such as Stryker Corporation and Abbott Laboratories. 

    Furthermore, in April 2023, ConMed's acquisition of a local South American competitor positioned it strategically within the region, enhancing its distribution network. Over the last couple of years, significant investments in technological advancements have been noted, with Thermo Fisher Scientific and Johnson and Johnson expanding their Research and Development efforts in South America, thus contributing to the overall market valuation and enhancing healthcare offerings for Piriformis Syndrome patients across the continent.

    Market Segmentation

    Piriformis Syndrome Market Cause Outlook

    • Trauma
    • Spasms
    • Others

    Piriformis Syndrome Market Regional Outlook

    • Brazil
    • Mexico
    • Argentina
    • Rest of South America

    Report Scope

     
    Report Attribute/Metric Source: Details
    MARKET SIZE 2023 18.37(USD Million)
    MARKET SIZE 2024 19.49(USD Million)
    MARKET SIZE 2035 34.0(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 5.191% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Million
    KEY COMPANIES PROFILED Zimmer Biomet, Medtronic, DePuy Synthes, Abbott Laboratories, Hologic, Aesculap, Baxter International, Stryker Corporation, ConMed, Thermo Fisher Scientific, Boston Scientific, Invacare Corporation, Smith & Nephew, NuVasive, Johnson & Johnson
    SEGMENTS COVERED Cause, Regional
    KEY MARKET OPPORTUNITIES Growing awareness and diagnosis, Increase in physical therapy services, Rising demand for minimally invasive treatments, Enhanced healthcare infrastructure, Expansion of telehealth services
    KEY MARKET DYNAMICS increasing prevalence of conditions, rising awareness among healthcare professionals, advancements in treatment options, growing demand for physical therapy, expanding healthcare infrastructure
    COUNTRIES COVERED Brazil, Mexico, Argentina, Rest of South America

    FAQs

    What is the expected market size of the South America Piriformis Syndrome Market in 2024?

    The South America Piriformis Syndrome Market is expected to be valued at 19.49 USD Million in 2024.

    What is the projected market size for the South America Piriformis Syndrome Market by 2035?

    By 2035, the market is projected to reach a value of 34.0 USD Million.

    What is the compound annual growth rate (CAGR) for the South America Piriformis Syndrome Market from 2025 to 2035?

    The expected CAGR for the South America Piriformis Syndrome Market from 2025 to 2035 is 5.191%.

    Which region holds the largest market share in the South America Piriformis Syndrome Market?

    Brazil holds the largest market share, valued at 6.5 USD Million in 2024.

    How is the South America Piriformis Syndrome Market divided by cause?

    The market is divided into three sub-segments: Trauma, Spasms, and Others.

    What is the market value for the Trauma segment of the South America Piriformis Syndrome Market in 2024?

    The Trauma segment is valued at 8.0 USD Million in 2024.

    What are some key players in the South America Piriformis Syndrome Market?

    Key players include Zimmer Biomet, Medtronic, and DePuy Synthes, among others.

    What is the expected value of the South America Piriformis Syndrome Market for the Spasms segment in 2035?

    The Spasms segment is expected to reach a value of 11.5 USD Million by 2035.

    What is the market size for Argentina in the South America Piriformis Syndrome Market in 2024?

    In 2024, the market size for Argentina is valued at 4.0 USD Million.

    What challenges are influencing the growth of the South America Piriformis Syndrome Market?

    Challenges include competition among key players and the need for innovative treatment solutions.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials